New drug approved for type 2 diabetes

accreditation
istock

Invokana (canaglifozin) has been approved by the US Food and Drug Administration to treat type 2 diabetes, which affects about 24 million Americans.

The drug is among a new class of medications called sodium-glucose co-transporter 2 inhibitors. It works to block re-absorption of glucose by the kidneys, leading to more glucose being excreted by the body, the agency said in a news release.

The drug's safety and effectiveness were evaluated in nine clinical trials involving more than 10 200 people. The trials showed improvement in blood glucose levels and glucose control, the FDA said.

Invokana, which users should combine with proper diet and exercise, shouldn't be taken by people with type 1 diabetes, by those who have elevated ketones of the blood or urine, or by people with kidney impairment or end stage renal disease, the FDA said.

The most common side effects noted during clinical testing included vaginal yeast infection and urinary tract infection. The FDA said it's ordering five post-marketing studies to evaluate the drug's effects on children, the cardiovascular system, and the potential for increased risk of cancer, pancreatitis, severe hypersentivity reactions, adverse pregnancy outcomes, bone safety, and liver abnormalities.

The drug may lead to a sudden drop in blood pressure when a user stands up, the agency said.

Invokana is produced for Janssen Pharmaceuticals of Titusville, NJ.

More information

Visit Medline Plus to learn more about type 2 diabetes.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
Eskom has considered continuous load shedding at Stage 2, instead of introducing it when the power system faces a crunch. What are your thoughts?
Please select an option Oops! Something went wrong, please try again later.
Results
I'm all for it - we're going to have power cuts regardless, so we might as well have some stability to better plan our lives
45% - 4416 votes
No thanks! I prefer having periods of no load shedding and we cannot normalise this crisis
55% - 5354 votes
Vote
Rand - Dollar
18.02
-0.4%
Rand - Pound
19.42
-0.2%
Rand - Euro
17.45
-0.5%
Rand - Aus dollar
11.75
-0.4%
Rand - Yen
0.13
-0.3%
Gold
1,645.34
+0.1%
Silver
18.73
-0.8%
Palladium
2,088.50
+0.8%
Platinum
863.00
+0.5%
Brent Crude
86.15
-5.0%
Top 40
56,949
-0.3%
All Share
63,220
-0.3%
Resource 10
55,903
-0.7%
Industrial 25
78,831
+0.5%
Financial 15
13,969
-1.2%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE